WO2006094247A3 - Amniotic membrane extracts, compositions thereof, and methods of use - Google Patents

Amniotic membrane extracts, compositions thereof, and methods of use

Info

Publication number
WO2006094247A3
WO2006094247A3 PCT/US2006/007776 US2006007776W WO2006094247A3 WO 2006094247 A3 WO2006094247 A3 WO 2006094247A3 US 2006007776 W US2006007776 W US 2006007776W WO 2006094247 A3 WO2006094247 A3 WO 2006094247A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
amniotic
membrane
invention
inflammation
scarring
Prior art date
Application number
PCT/US2006/007776
Other languages
French (fr)
Other versions
WO2006094247A2 (en )
Inventor
Scheffer Cg Tseng
David Y Tseng
Wei Li
Hua He
Original Assignee
Tissuetech Inc
Scheffer Cg Tseng
David Y Tseng
Wei Li
Hua He
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells

Abstract

The present invention relates to the prevention and reduction of scarring and inflammation by amniotic membrane extracts or compositions thereof. The invention also relates to the preparation of soluble and fractionated amniotic membrane extracts and the preparation of gels comprising the amniotic membrane extract for enhanced use and application. The invention further provides an extract composition of amniotic membrane that is effective in the prevention and reduction of scarring and inflammation by suppression of TGF-β activity. The invention further provides a method for reducing scarring and inflammation, and enhancing healing of wounds. The invention also provides purified lumican from human AM for the treatment of scarring and inflammation.
PCT/US2006/007776 2005-03-02 2006-03-02 Amniotic membrane extracts, compositions thereof, and methods of use WO2006094247A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US65739905 true 2005-03-02 2005-03-02
US60/657,399 2005-03-02

Publications (2)

Publication Number Publication Date
WO2006094247A2 true WO2006094247A2 (en) 2006-09-08
WO2006094247A3 true true WO2006094247A3 (en) 2006-10-26

Family

ID=36941885

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/007776 WO2006094247A3 (en) 2005-03-02 2006-03-02 Amniotic membrane extracts, compositions thereof, and methods of use

Country Status (1)

Country Link
WO (1) WO2006094247A3 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9161956B2 (en) 2005-09-27 2015-10-20 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and anti-inflammation methods

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
WO2008060377A3 (en) * 2006-10-04 2008-08-21 Anthrogenesis Corp Placental or umbilical cord tissue compositions
US9175066B2 (en) 2009-04-24 2015-11-03 Tissuetech, Inc. Compositions containing HC-HA complex and methods of use thereof
EP2536827B1 (en) 2010-02-18 2018-01-10 Osiris Therapeutics, Inc. Methods of manufacture of therapeutic products comprising vitalized placental dispersions
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
WO2012170905A1 (en) 2011-06-10 2012-12-13 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
WO2014040026A3 (en) * 2012-09-10 2015-07-23 Wake Forest University Health Sciences Amniotic membrane and its use in wound healing and tissue engineering constructs
US9795639B1 (en) 2013-03-16 2017-10-24 BioDlogics, LLC Methods for the treatment of erectile dysfunction by human birth tissue material compostion
EP3019186A4 (en) * 2013-07-12 2017-03-29 Patrick J Casey Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
CN106456675A (en) 2014-06-03 2017-02-22 组织技术公司 Compositions and methods
WO2017171706A1 (en) * 2016-03-28 2017-10-05 Tello Celso Amniotic or placental preparation and device for ophthalmic use as a dressing to enhance healing

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040057938A1 (en) * 2002-09-18 2004-03-25 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040057938A1 (en) * 2002-09-18 2004-03-25 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9161956B2 (en) 2005-09-27 2015-10-20 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and anti-inflammation methods

Also Published As

Publication number Publication date Type
WO2006094247A2 (en) 2006-09-08 application

Similar Documents

Publication Publication Date Title
WO2006099261A3 (en) Potent and specific immunoproteasome inhibitors
CA2546464A1 (en) Sequential application of oral and topical formulations for treating wrinkles and other damage to skin
CA2667392A1 (en) Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors
WO2005032493A8 (en) Amide compounds as ion channel ligands and uses thereof
WO2011148257A1 (en) Kit of parts for treating and/or preventing cutaneous ulcers
WO2006113864A3 (en) Oxindole compounds and their uses as therapeutic agents
Omer et al. Irritant contact dermatitis caused by Ranunculus kotschyi Boiss in 6 cases
Watanabe et al. Pruni cortex ameliorates skin inflammation possibly through HMGB1-NFκB pathway in house dust mite induced atopic dermatitis NC/Nga transgenic mice
EP2632475B1 (en) Compositions for the treatment of peripheral ulcers of various origins
JP4614423B2 (en) Allergic rhinitis nasal composition
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
CN104307032A (en) Liquid dressing capable of stopping pain and bleeding, resisting bacteria and promoting wound healing
CA2656915A1 (en) Human protein tyrosine phosphatase inhibitors and methods of use
WO2006039691A3 (en) Morphine and morphine precursors
Masci EAU de PHILAE
Pereira et al. Lafoensia pacari A. St.-Hil.: Wound healing activity and mechanism of action of standardized hydroethanolic leaves extract
Suthar et al. WOUND HEALING POTENCY OF ETHANOLIC EXTRACT OF LEUCAS URTICIFOLIA IN EXPERIMENTAL ANIMALS
JP2002338487A (en) Drug for external use
WO2013177067A3 (en) Herbal composition for treatment of gastrointestinal inflammatory diseases and method to prepare and use thereof
JP6026540B2 (en) Therapeutic compositions of peripheral ulcer of different causes
CN105193659A (en) Aloe-containing composition for controlling oil and removing acnes
WO2006124874A3 (en) Inhibitors of b-raf kinase
WO2007069015A3 (en) Cosmetic compositions based on essential oils and use thereof in pain relief
JP2009221127A (en) Cosmetic
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

NENP Non-entry into the national phase in:

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06737006

Country of ref document: EP

Kind code of ref document: A2